The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity
Journal of Neurology Research · 2026-09 · 16 (3) · 127-140
DOI: 10.14740/jnr1115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurology Research, 2026-09. Verfasst von Mitchell B. Liester und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liester, M. B., Liang, B., & Schwartz, L. (2026). The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity. Journal of Neurology Research, 16(3), 127-140. https://doi.org/10.14740/jnr1115
Vancouver
Liester MB, Liang B, Schwartz L. The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity. Journal of Neurology Research. 2026;16(3):127-140. doi:10.14740/jnr1115
BibTeX
@article{Liester2026,
author = {Liester, Mitchell B. and Liang, Bertrand and Schwartz, Laurent},
title = {The Therapeutic Potential of Ketamine as a Treatment for Amyotrophic Lateral Sclerosis: A Narrative Review Focusing on Sigma-1 Receptor Modulation, Mitochondrial Function, and Neuroplasticity},
journal = {Journal of Neurology Research},
year = {2026},
volume = {16},
number = {3},
pages = {127--140},
doi = {10.14740/jnr1115}
}
EUVIMED